没有证据表明COVID-19预印稿和同行评审出版物之间治疗效果总结的重要差异:一项元流行病学研究
Mauricia Davidson1, Theodoros Evrenoglou1, Carolina Graña2
1Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and Statistics (CRESS), F-75004 Paris, France.
从COVID-19预版和同行评审出版物中总结治疗效应没有显著差异. 这一发现表明,预版与期刊文章可比,用于系统性审查中的治疗效果估计.
科学领域:
- 医学研究 医学研究
- 流行病学 流行病学
- 健康科学 卫生科学 卫生科学
背景情况:
- 在COVID-19大流行期间,预印在研究交流中占据了突出地位.
- 评估预版与同行评审出版物之间治疗效果估计的潜在差异对于证据综合至关重要.
结论:
- 从预版中获得的总结处理效果与同行评审出版物的效果相似.
- 系统审查员和指导方针开发人员应单独评估预印稿,考虑偏见风险和报告完整性.
- 这些发现支持将预印件纳入证据综合,并进行适当的批判性评估.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
相关概念视频
Bias in Epidemiological Studies
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Statistical Methods for Analyzing Epidemiological Data
Single Nucleotide Polymorphisms-SNPs
Introduction to Epidemiology
